Credit Suisse’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Credit Suisse’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-359,972	Closed	-$12.4M	–	4806
2014 Q4	$12.4M	Buy	359,972 +47,624	+15%	+$1.55M	0.01%	1141
2014 Q3	$9.32M	Buy	312,348 +199,094	+176%	+$4.22M	0.01%	1331
2014 Q2	$2.27M	Buy	113,254 +2,388	+2%	+$54.8K	﹤0.01%	2607
2014 Q1	$3.01M	Sell	110,866 -106,774	-49%	-$2.83M	﹤0.01%	2198
2013 Q4	$4.51M	Buy	217,640 +101,207	+87%	+$1.91M	﹤0.01%	1935
2013 Q3	$2.12M	Sell	116,433 -6,353	-5%	-$115K	﹤0.01%	2342
2013 Q2	$2.04M	Buy	+122,786	New	+$1.96M	﹤0.01%	2251

Other funds holding AUXL

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Credit Suisse's AUXL Position: Q1 2015 in Review

Credit Suisse sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 359,972 shares — an estimated $12.4M sold.

Credit Suisse first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $12.4M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

Credit Suisse reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Credit Suisse sold 359,972 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $12.4M.
Credit Suisse first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
Credit Suisse's AUXILIUM PHARAMCEUTICALS INC position peaked at $12.4M in Q4 2014.
1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Credit Suisse's 13F filing for Q1 2015, filed 6 May 2015.